226 related articles for article (PubMed ID: 14763133)
1. CMT-3. CollaGenex.
Fingleton B
Curr Opin Investig Drugs; 2003 Dec; 4(12):1460-7. PubMed ID: 14763133
[TBL] [Abstract][Full Text] [Related]
2. MEN-10755. Menarini.
Jones K
Curr Opin Investig Drugs; 2003 Dec; 4(12):1473-8. PubMed ID: 14763135
[TBL] [Abstract][Full Text] [Related]
3. CKD-602. Chong Kun Dang.
Crul M
Curr Opin Investig Drugs; 2003 Dec; 4(12):1455-9. PubMed ID: 14763132
[TBL] [Abstract][Full Text] [Related]
4. 109881 Aventis.
Ojima I; Geney R
Curr Opin Investig Drugs; 2003 Jun; 4(6):737-40. PubMed ID: 12901234
[TBL] [Abstract][Full Text] [Related]
5. Diflomotecan. Ipsen.
Osheroff N
IDrugs; 2004 Mar; 7(3):257-63. PubMed ID: 15011101
[No Abstract] [Full Text] [Related]
6. BMS-247550 Bristol-Myers Squibb/GBF.
Lin N; Brakora K; Seiden M
Curr Opin Investig Drugs; 2003 Jun; 4(6):746-56. PubMed ID: 12901236
[TBL] [Abstract][Full Text] [Related]
7. Cilengitide Merck.
Smith JW
Curr Opin Investig Drugs; 2003 Jun; 4(6):741-5. PubMed ID: 12901235
[TBL] [Abstract][Full Text] [Related]
8. Lerisetron. FAES.
Huckle R
Curr Opin Investig Drugs; 2003 Jul; 4(7):874-7. PubMed ID: 14619411
[TBL] [Abstract][Full Text] [Related]
9. Lapatinib ditosylate GlaxoSmithKline.
Kim TE; Murren JR
IDrugs; 2003 Sep; 6(9):886-93. PubMed ID: 12964069
[TBL] [Abstract][Full Text] [Related]
10. BAY-43-9006 Bayer/Onyx.
Lee JT; McCubrey JA
Curr Opin Investig Drugs; 2003 Jun; 4(6):757-63. PubMed ID: 12901237
[TBL] [Abstract][Full Text] [Related]
11. Technology evaluation: TNFerade, GenVec.
Kircheis R; Wagner E
Curr Opin Mol Ther; 2003 Aug; 5(4):437-47. PubMed ID: 14513689
[TBL] [Abstract][Full Text] [Related]
12. Chemically modified tetracyclines as inhibitors of matrix metalloproteinases.
Acharya MR; Venitz J; Figg WD; Sparreboom A
Drug Resist Updat; 2004 Jun; 7(3):195-208. PubMed ID: 15296861
[TBL] [Abstract][Full Text] [Related]
13. GSK3 inhibitors: development and therapeutic potential.
Cohen P; Goedert M
Nat Rev Drug Discov; 2004 Jun; 3(6):479-87. PubMed ID: 15173837
[No Abstract] [Full Text] [Related]
14. Nemifitide. Innapharma.
Dingemanse J
Curr Opin Investig Drugs; 2003 Jul; 4(7):859-62. PubMed ID: 14619408
[TBL] [Abstract][Full Text] [Related]
15. ONO-2506. Ono.
de Paulis T
Curr Opin Investig Drugs; 2003 Jul; 4(7):863-7. PubMed ID: 14619409
[TBL] [Abstract][Full Text] [Related]
16. Clofarabine. Bioenvision/ILEX.
Sternberg A
Curr Opin Investig Drugs; 2003 Dec; 4(12):1479-87. PubMed ID: 14763136
[TBL] [Abstract][Full Text] [Related]
17. ZD-6474. AstraZeneca.
Bates D
Curr Opin Investig Drugs; 2003 Dec; 4(12):1468-72. PubMed ID: 14763134
[TBL] [Abstract][Full Text] [Related]
18. Glyminox Biosyn.
Witherell GW
Curr Opin Investig Drugs; 2004 Feb; 5(2):222-31. PubMed ID: 15043398
[TBL] [Abstract][Full Text] [Related]
19. AE-941 (AEterna).
Dredge K
Curr Opin Investig Drugs; 2004 Jun; 5(6):668-77. PubMed ID: 15242256
[TBL] [Abstract][Full Text] [Related]
20. ZD-0892 AstraZeneca.
Ohbayashi H
Curr Opin Investig Drugs; 2000 Oct; 1(2):227-9. PubMed ID: 11249578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
